Sun Pharma to Acquire Concert Pharmaceuticals | Advancing t

Adds Deuruxolitinib, a Potential Best-in-Class Oral JAK Inhibitor for the Treatment of Alopecia Areata, an Autoimmune Dermatological Disease
Leverages Sun ...

Related Keywords

Sun Pharma , Sun Pharma To Acquire Concert Pharmaceuticals , Acquire Concert Pharmaceuticals , Potential Treatment , Alopecia Areata , Adds Deuruxolitinib , Potential Best In Class Oral , Global Infrastructure , Provide Broad Access , Alopeciaareata Strengthens Sun Pharma , Global Dermatology Franchise , Late Stage Product , Significant Unmet Need Sun Pharma , Commence Tender Offer , Acquire All Outstanding Shares , Common Stock , Concert Upfront Cash Payment , Equity Consideration , Contingent Value Right , Certain Time Based Net Sales , Sun , Dharma , Cquire , Concert , Pharmaceuticals , Dvancing , The , Potential , Treatment , Alopecia , Areata , ,